Detalhe da pesquisa
1.
Noninvasive Early Identification of Therapeutic Benefit from Immune Checkpoint Inhibition.
Cell
; 183(2): 363-376.e13, 2020 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33007267
2.
Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery.
Immunity
; 54(3): 586-602.e8, 2021 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33691136
3.
Integrating genomic features for non-invasive early lung cancer detection.
Nature
; 580(7802): 245-251, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32269342
4.
Top advances of the year: Perioperative therapy for lung cancer.
Cancer
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38717993
5.
Risk model-based management for second primary lung cancer among lung cancer survivors through a validated risk prediction model.
Cancer
; 130(5): 770-780, 2024 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37877788
6.
Identification of Pathogenic Immune Cell Subsets Associated With Checkpoint Inhibitor-Induced Myocarditis.
Circulation
; 146(4): 316-335, 2022 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35762356
7.
Giant Magnetoresistive Nanosensor Analysis of Circulating Tumor DNA Epidermal Growth Factor Receptor Mutations for Diagnosis and Therapy Response Monitoring.
Clin Chem
; 67(3): 534-542, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33393992
8.
Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases.
J Neurooncol
; 152(1): 125-134, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-33415659
9.
Osimertinib for EGFR-Mutant Lung Cancer with Brain Metastases: Results from a Single-Center Retrospective Study.
Oncologist
; 24(6): 836-843, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30126856
10.
Case series of MET exon 14 skipping mutation-positive non-small-cell lung cancers with response to crizotinib and cabozantinib.
Anticancer Drugs
; 30(5): 537-541, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30762593
11.
Molecular profiling of single circulating tumor cells from lung cancer patients.
Proc Natl Acad Sci U S A
; 113(52): E8379-E8386, 2016 12 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-27956614
12.
Rociletinib in EGFR-mutated non-small-cell lung cancer.
N Engl J Med
; 372(18): 1700-9, 2015 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-25923550
13.
Adjuvant chemotherapy with or without bevacizumab in patients with resected non-small-cell lung cancer (E1505): an open-label, multicentre, randomised, phase 3 trial.
Lancet Oncol
; 18(12): 1610-1623, 2017 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-29129443
14.
Targeting BRAF-Mutant Non-Small Cell Lung Cancer: From Molecular Profiling to Rationally Designed Therapy.
Oncologist
; 22(7): 786-796, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28487464
15.
Anaplastic Lymphoma Kinase Testing: IHC vs. FISH vs. NGS.
Curr Treat Options Oncol
; 18(12): 71, 2017 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-29143897
16.
Erlotinib, cabozantinib, or erlotinib plus cabozantinib as second-line or third-line treatment of patients with EGFR wild-type advanced non-small-cell lung cancer (ECOG-ACRIN 1512): a randomised, controlled, open-label, multicentre, phase 2 trial.
Lancet Oncol
; 17(12): 1661-1671, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27825638
17.
Physical activity and sedentary behavior in relation to lung cancer incidence and mortality in older women: The Women's Health Initiative.
Int J Cancer
; 139(10): 2178-92, 2016 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27439221
18.
Statin use and all-cancer survival: prospective results from the Women's Health Initiative.
Br J Cancer
; 115(1): 129-35, 2016 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-27280630
19.
Protective Effects of Statins in Cancer: Should They Be Prescribed for High-Risk Patients?
Curr Atheroscler Rep
; 18(12): 72, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27796821
20.
Resistance to Therapy.
Cancer Treat Res
; 170: 183-202, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-27535395